184 related articles for article (PubMed ID: 32812215)
1. Characterization of circulating immune cells in acute Kawasaki disease suggests exposure to different antigens.
Burns JC; Hsieh LE; Kumar J; Behnamfar N; Shimizu C; Sivilay N; Tremoulet AH; Franco A
Clin Exp Immunol; 2020 Dec; 202(3):263-272. PubMed ID: 32812215
[TBL] [Abstract][Full Text] [Related]
2. Immune-monitoring in Kawasaki disease patients treated with infliximab and intravenous immunoglobulin.
Burns JC; Song Y; Bujold M; Shimizu C; Kanegaye JT; Tremoulet AH; Franco A
Clin Exp Immunol; 2013 Dec; 174(3):337-44. PubMed ID: 23901839
[TBL] [Abstract][Full Text] [Related]
3. Intravenous Immunoglobulin Therapy Restores the Quantity and Phenotype of Circulating Dendritic Cells and CD4
Wang N; Chen Z; Zhang F; Zhang Q; Sun L; Lv H; Wang B; Shen J; Zhou X; Chen F; Zhang B; Meng L; Zhou H; Bai Z; Huang J
Front Immunol; 2022; 13():802690. PubMed ID: 35222381
[TBL] [Abstract][Full Text] [Related]
4. Fine specificities of natural regulatory T cells after IVIG therapy in patients with Kawasaki disease.
Burns JC; Touma R; Song Y; Padilla RL; Tremoulet AH; Sidney J; Sette A; Franco A
Autoimmunity; 2015 May; 48(3):181-8. PubMed ID: 25822882
[TBL] [Abstract][Full Text] [Related]
5. Aberrantly decreased levels of NKG2D expression in children with kawasaki disease.
Ge X; Li CR; Yang J; Wang GB
Scand J Immunol; 2013 May; 77(5):389-97. PubMed ID: 23298273
[TBL] [Abstract][Full Text] [Related]
6. High Dose Intravenous IgG Therapy Modulates Multiple NK Cell and T Cell Functions in Patients With Immune Dysregulation.
McAlpine SM; Roberts SE; Heath JJ; Käsermann F; Issekutz AC; Issekutz TB; Derfalvi B
Front Immunol; 2021; 12():660506. PubMed ID: 34093549
[TBL] [Abstract][Full Text] [Related]
7. Intravenous immunoglobulin induces IgG internalization by tolerogenic myeloid dendritic cells that secrete IL-10 and expand Fc-specific regulatory T cells.
Hsieh LE; Song J; Tremoulet AH; Burns JC; Franco A
Clin Exp Immunol; 2022 Jun; 208(3):361-371. PubMed ID: 35536993
[TBL] [Abstract][Full Text] [Related]
8. Changes in Peripheral Blood Neutrophils, Lymphocytes and IL-10 in Children with Kawasaki Disease from Different Age Groups Undergoing Intravenous Immunoglobulin: A Retrospective Study.
Zhang C; Zhang X; Shen J; Lu X; Zhang J; Chen S
Mediators Inflamm; 2020; 2020():5213451. PubMed ID: 33293897
[TBL] [Abstract][Full Text] [Related]
9. Memory T-cells and characterization of peripheral T-cell clones in acute Kawasaki disease.
Franco A; Shimizu C; Tremoulet AH; Burns JC
Autoimmunity; 2010 Jun; 43(4):317-24. PubMed ID: 20166878
[TBL] [Abstract][Full Text] [Related]
10. Single-cell RNA sequencing of peripheral blood mononuclear cells from acute Kawasaki disease patients.
Wang Z; Xie L; Ding G; Song S; Chen L; Li G; Xia M; Han D; Zheng Y; Liu J; Xiao T; Zhang H; Huang Y; Li Y; Huang M
Nat Commun; 2021 Sep; 12(1):5444. PubMed ID: 34521850
[TBL] [Abstract][Full Text] [Related]
11. Intravenous immunoglobulin treatment responsiveness depends on the degree of CD8+ T cell activation in Kawasaki disease.
Ye Q; Gong FQ; Shang SQ; Hu J
Clin Immunol; 2016 Oct; 171():25-31. PubMed ID: 27519954
[TBL] [Abstract][Full Text] [Related]
12. Distribution of distinct subsets of circulating T follicular helper cells in Kawasaki disease.
Xu M; Jiang Y; Wang J; Liu D; Wang S; Yi H; Yang S
BMC Pediatr; 2019 Jan; 19(1):43. PubMed ID: 30704426
[TBL] [Abstract][Full Text] [Related]
13. Expression of CD40 ligand on CD4+ T-cells and platelets correlated to the coronary artery lesion and disease progress in Kawasaki disease.
Wang CL; Wu YT; Liu CA; Lin MW; Lee CJ; Huang LT; Yang KD
Pediatrics; 2003 Feb; 111(2):E140-7. PubMed ID: 12563087
[TBL] [Abstract][Full Text] [Related]
14. Dynamics of immunocyte activation during intravenous immunoglobulin treatment in Kawasaki disease.
Matsuguma C; Wakiguchi H; Suzuki Y; Okada S; Furuta T; Ohnishi Y; Azuma Y; Ohga S; Hasegawa S
Scand J Rheumatol; 2019 Nov; 48(6):491-496. PubMed ID: 31272272
[No Abstract] [Full Text] [Related]
15. Clinical characteristics and outcomes of children with Kawasaki disease combined with sepsis in the pediatric intensive care unit.
Yang Y; Huang J; Yan H; Li X; Liu P; Zhou W; Zhang X; Lu X; Xiao Z
Front Cell Infect Microbiol; 2023; 13():1101428. PubMed ID: 37234775
[TBL] [Abstract][Full Text] [Related]
16. Lack of CD4⁺CD25⁺FOXP3⁺ regulatory T cells is associated with resistance to intravenous immunoglobulin therapy in patients with Kawasaki disease.
Hirabayashi Y; Takahashi Y; Xu Y; Akane K; Villalobos IB; Okuno Y; Hasegawa S; Muramatsu H; Hama A; Kato T; Kojima S
Eur J Pediatr; 2013 Jun; 172(6):833-7. PubMed ID: 23340699
[TBL] [Abstract][Full Text] [Related]
17. The immunomodulatory effects of intravenous immunoglobulin therapy in Kawasaki disease.
Burns JC; Franco A
Expert Rev Clin Immunol; 2015; 11(7):819-25. PubMed ID: 26099344
[TBL] [Abstract][Full Text] [Related]
18. Increased Pentraxin 3 Levels Correlate With IVIG Responsiveness and Coronary Artery Aneurysm Formation in Kawasaki Disease.
Kitoh T; Ohara T; Muto T; Okumura A; Baba R; Koizumi Y; Yamagishi Y; Mikamo H; Daigo K; Hamakubo T
Front Immunol; 2021; 12():624802. PubMed ID: 33912155
[TBL] [Abstract][Full Text] [Related]
19. Serum resistin concentrations in children with Kawasaki disease.
Nozue H; Imai H; Saitoh H; Aoki T; Ichikawa K; Kamoda T
Inflamm Res; 2010 Nov; 59(11):915-20. PubMed ID: 20422438
[TBL] [Abstract][Full Text] [Related]
20. Gene-expression patterns reveal underlying biological processes in Kawasaki disease.
Popper SJ; Shimizu C; Shike H; Kanegaye JT; Newburger JW; Sundel RP; Brown PO; Burns JC; Relman DA
Genome Biol; 2007; 8(12):R261. PubMed ID: 18067656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
